🇺🇸 FDA
Patent

US 7001884

Eglin c based drugs for treatment of disease

expired A61KA61K38/58

Quick answer

US patent 7001884 (Eglin c based drugs for treatment of disease) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/58